These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 12069128)
1. Pleural to serum CEA ratio in lung adenocarcinoma. Satoh H; Ishikawa H; Yamashita YT; Ohtsuka M; Sekizawa K Clin Oncol (R Coll Radiol); 2002 Apr; 14(2):178-9. PubMed ID: 12069128 [No Abstract] [Full Text] [Related]
2. Lung surfactant protein-A and carcinoembryonic antigen in pleural effusions due to lung adenocarcinoma and malignant mesothelioma. Shijubo N; Honda Y; Fujishima T; Takahashi H; Kodama T; Kuroki Y; Akino T; Abe S Eur Respir J; 1995 Mar; 8(3):403-6. PubMed ID: 7789485 [TBL] [Abstract][Full Text] [Related]
3. Value of serum and effusion fluid CEA levels for distinguishing between diffuse malignant mesothelioma and carcinomatous pleural metastases. Mezger J; Calavrezos A; Drings P; Gatzemeier U; Kaukel E; Konietzko N; Koschel G; Lamerz R; von Pawel J; Römer W Lung; 1994; 172(3):183-4. PubMed ID: 8201832 [No Abstract] [Full Text] [Related]
4. Improvement of the diagnosis of the cause of pleural effusion in patients with lung cancer by simultaneous quantification of carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) pleural levels. Menard O; Dousset B; Jacob C; Martinet Y Eur J Cancer; 1993; 29A(13):1806-9. PubMed ID: 8260229 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of serum and pleural levels of soluble B7-H4 in lung cancer patients with pleural effusion. Xu C; Qian L; Yu L; Zhang X; Wang Q Biomarkers; 2015; 20(4):271-4. PubMed ID: 26301886 [TBL] [Abstract][Full Text] [Related]
6. [The value of B7-H4 and carcinoembryonic antigen in diagnosing the benign and malignant pleural effusion]. Wei F; Wei Y; Li LF; Li GL; Wang GJ Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):524-527. PubMed ID: 28728299 [No Abstract] [Full Text] [Related]
7. Diagnostic value of tumor markers for lung adenocarcinoma-associated malignant pleural effusion: a validation study and meta-analysis. Feng M; Zhu J; Liang L; Zeng N; Wu Y; Wan C; Shen Y; Wen F Int J Clin Oncol; 2017 Apr; 22(2):283-290. PubMed ID: 27990560 [TBL] [Abstract][Full Text] [Related]
8. Soluble oncoprotein 185HER-2 in pleural fluid has limited usefulness for the diagnostic evaluation of malignant effusions. Porcel JM; Salud A; Vives M; Esquerda A; Rodríguez-Panadero F Clin Biochem; 2005 Nov; 38(11):1031-3. PubMed ID: 15925354 [TBL] [Abstract][Full Text] [Related]
9. [Value of tumor markers series of hydrothorax in differential diagnosis of pleural effusion]. Liu YQ; Zhang HL; Gao WJ; Lan X; Yuan BJ; Zou JM Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2008 Jan; 26(1):34-8. PubMed ID: 18302890 [TBL] [Abstract][Full Text] [Related]
10. Downregulation of cell-free miR-198 as a diagnostic biomarker for lung adenocarcinoma-associated malignant pleural effusion. Han HS; Yun J; Lim SN; Han JH; Lee KH; Kim ST; Kang MH; Son SM; Lee YM; Choi SY; Yun SJ; Kim WJ; Lee OJ Int J Cancer; 2013 Aug; 133(3):645-52. PubMed ID: 23354517 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of serum and pleural levels of the tumor markers CEA, CYFRA21-1 and CA 15-3 in patients with pleural effusion. Wagner IC; Guimarães MJ; da Silva LK; de Melo FM; Muniz MT J Bras Pneumol; 2007; 33(2):185-91. PubMed ID: 17724538 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in differentiating malignant from benign pleural effusion. Dong J; Sun G; Zhu H Tumour Biol; 2016 Mar; 37(3):3257-64. PubMed ID: 26438059 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of CYFRA 21-1 tumor marker and CEA in pleural effusion due to mesothelioma. Paganuzzi M; Onetto M; Marroni P; Filiberti R; Tassara E; Parodi S; Felletti R Chest; 2001 Apr; 119(4):1138-42. PubMed ID: 11296181 [TBL] [Abstract][Full Text] [Related]
14. CEA, CA 15-3 and CYFRA 21-1 in serum and pleural fluid of patients with pleural effusions. Romero S; Fernández C; Arriero JM; Espasa A; Candela A; Martín C; Sánchez-Payá J Eur Respir J; 1996 Jan; 9(1):17-23. PubMed ID: 8834328 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of cytokeratin 19 fragment (CYFRA 21-1) as a tumor marker in malignant pleural effusion. Lai RS; Chen CC; Lee PC; Lu JY Jpn J Clin Oncol; 1999 Sep; 29(9):421-4. PubMed ID: 10563194 [TBL] [Abstract][Full Text] [Related]
16. Analysis of tumor markers in pleural effusion and serum to verify the correlations between serum tumor markers and tumor size, TNM stage of lung adenocarcinoma. Chen Z; Wang Y; Fang M Cancer Med; 2020 Feb; 9(4):1392-1399. PubMed ID: 31881123 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of serum and pleural levels of endostatin and vascular epithelial growth factor in lung cancer patients with pleural effusion. Zhang Y; Yu LK; Xia N Asian Pac J Trop Med; 2012 Mar; 5(3):239-42. PubMed ID: 22305792 [TBL] [Abstract][Full Text] [Related]
18. [Prognostic value of the carcinoembryonic antigen found in pleural lavage fluid from patients with lung carcinoma]. Galbis Caravajal JM; Benlloch Carrión S; Sánchez Payá J; Mafé Madueño JJ; Baschwitz Gómez B; Rodríguez Paniagua JM Arch Bronconeumol; 2005 Apr; 41(4):185-8. PubMed ID: 15826527 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of tumor markers in lung adenocarcinoma-associated cytologically negative pleural effusions. Hsieh TC; Huang WW; Lai CL; Tsao SM; Su CC Cancer Cytopathol; 2013 Sep; 121(9):483-8. PubMed ID: 23408492 [TBL] [Abstract][Full Text] [Related]
20. Performance of CEA and CA19-9 in identifying pleural effusions caused by specific malignancies. Hackbarth JS; Murata K; Reilly WM; Algeciras-Schimnich A Clin Biochem; 2010 Sep; 43(13-14):1051-5. PubMed ID: 20529669 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]